• Published On : Sep-2018 |
  • Pages : 245 Pages |
  • Format :

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Postoperative Pain Management Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Background
     4.1. Market Dynamics
            4.1.1. Drivers
            4.1.2. Restraints
            4.1.3. Trends
     4.2. Regulatory Scenario

5. Global Economic Outlook
     5.1. Gross Domestic Product by Region & Country, 2006 – 2021
     5.2. Global Healthcare Market Outlook

6. Key Inclusions
     6.1. Key Distributors List

7. North America Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
            7.2.1. U.S.
            7.2.2. Canada
     7.3. Market Size (US$ Mn) Forecast By Coun
     7.4. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            7.4.1. Opioids
            7.4.2. NSAIDS
            7.4.3. Local Anaesthetics
            7.4.4. Acetaminophen
     7.5. Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            7.6.1. Injectable
            7.6.2. Oral
            7.6.3. Topical
            7.6.4. Transdermal
            7.6.5. Others
     7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     7.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            7.8.1. Hospital Pharmacies
            7.8.2. Retail Pharmacies
            7.8.3. Drug Store
            7.8.4. Clinics
            7.8.5. Others
     7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     7.10.Market Attractiveness Analysis
            7.10.1. By Country
            7.10.2. By Drug Class
            7.10.3. By Route of Administration
            7.10.4. By Distribution Channel
     7.11.Key Market Participants – Intensity Mapping
     7.12.Drivers and Restraints – Impact Analysis

8. Latin America Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
            8.2.1. Brazil
            8.2.2. Mexico
            8.2.3. Rest of Latin America
     8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     8.4. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            8.4.1. Opioids
            8.4.2. NSAIDS
            8.4.3. Local Anaesthetics
            8.4.4. Acetaminophen
     8.5. Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            8.6.1. Injectables
            8.6.2. Oral
            8.6.3. Topical
            8.6.4. Transdermal
            8.6.5. Others
     8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     8.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            8.8.1. Hospital Pharmacies
            8.8.2. Retail Pharmacies
            8.8.3. Drug Store
            8.8.4. Clinics
            8.8.5. Others
     8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     8.10.Market Attractiveness Analysis
            8.10.1. By Country
            8.10.2. By Drug Class
            8.10.3. By Route of Administration
            8.10.4. By Distribution Channel
     8.11.Key Market Participants – Intensity Mapping
     8.12.Drivers and Restraints – Impact Analysis

9. Europe Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Regional Market Trends
     9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            9.3.1. U.K.
            9.3.2. Germany
            9.3.3. France
            9.3.4. Italy
            9.3.5. Spain
            9.3.6. Russia
            9.3.7. Rest of Europe
     9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     9.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            9.5.1. Opioids
            9.5.2. NSAIDS
            9.5.3. Local Anaesthetics
            9.5.4. Acetaminophen
     9.6. Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     9.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            9.7.1. Injectables
            9.7.2. Oral
            9.7.3. Topical
            9.7.4. Transdermal
            9.7.5. Others
     9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            9.9.1. Hospital Pharmacies
            9.9.2. Retail Pharmacies
            9.9.3. Drug Store
            9.9.4. Clinics
            9.9.5. Others
     9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     9.11.Market Attractiveness Analysis
            9.11.1. By Country
            9.11.2. By Drug Class
            9.11.3. By Route of Administration
            9.11.4. By Distribution Channel
     9.12.Key Market Participants – Intensity Mapping
     9.13.Drivers and Restraints – Impact Analysis

10. Asia Pacific Excluding China Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     10.1.Introduction
     10.2.Regional Market Trends
     10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            10.3.1. Japan
            10.3.2. India
            10.3.3. Australia and New Zealand
            10.3.4. ASEAN
            10.3.5. Rest of Asia Pacific
     10.4.Market Size (US$ Mn) Forecast By Country, 2018–2026
     10.5.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            10.5.1. Opioids
            10.5.2. NSAIDS
            10.5.3. Local Anaesthetics
            10.5.4. Acetaminophen
     10.6.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     10.7.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            10.7.1. Injectables
            10.7.2. Oral
            10.7.3. Topical
            10.7.4. Transdermal
            10.7.5. Others
     10.8.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     10.9.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            10.9.1. Hospital Pharmacies
            10.9.2. Retail Pharmacies
            10.9.3. Drug Store
            10.9.4. Clinics
            10.9.5. Others
     10.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     10.11.Market Attractiveness Analysis
            10.11.1. By Country
            10.11.2. By Drug Class
            10.11.3. By Route of Administration
            10.11.4. By Distribution Channel
     10.12. Key Market Participants – Intensity Mapping
     10.13. Drivers and Restraints – Impact Analysis

11. China Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     11.1.Introduction
     11.2.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            11.2.1. Opioids
            11.2.2. NSAIDS
            11.2.3. Local Anaesthetics
            11.2.4. Acetaminophen
     11.3.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     11.4.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            11.4.1. Injectables
            11.4.2. Oral
            11.4.3. Topical
            11.4.4. Transdermal
            11.4.5. Others
     11.5.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     11.6.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            11.6.1. Hospital Pharmacies
            11.6.2. Retail Pharmacies
            11.6.3. Drug Store
            11.6.4. Clinics
            11.6.5. Others
     11.7.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     11.8.Market Attractiveness Analysis
            11.8.1. By Drug Class
            11.8.2. By Route of Administration
            11.8.3. By Distribution Channel
     11.9.Key Market Participants – Intensity Mapping
     11.10. Drivers and Restraints – Impact Analysis

12. Middle East & Africa Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     12.1.Introduction
     12.2.Regional Market Trends
     12.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            12.3.1. South Africa
            12.3.2. GCC Countries
            12.3.3. Rest of MEA
     12.4.Market Size (US$ Mn) Forecast By Country, 2018–2026
     12.5.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            12.5.1. Opioids
            12.5.2. NSAIDS
            12.5.3. Local Anaesthetics
            12.5.4. Acetaminophen
     12.6.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     12.7.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            12.7.1. Injectables
            12.7.2. Oral
            12.7.3. Topical
            12.7.4. Transdermal
            12.7.5. Others
     12.8.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     12.9.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            12.9.1. Hospital Pharmacies
            12.9.2. Retail Pharmacies
            12.9.3. Drug Store
            12.9.4. Clinics
            12.9.5. Others
     12.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     12.11.Market Attractiveness Analysis
            12.11.1. By Country
            12.11.2. By Drug Class
            12.11.3. By Route of Administration
            12.11.4. By Distribution Channel
     12.12. Key Market Participants – Intensity Mapping
     12.13. Drivers and Restraints – Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis
     15.1.Market Structure Analysis by Tier
     15.2.Company Share Analysis (2017)

16. Competition Landscape
     16.1.Market Structure Analysis
     16.2.Competition Dashboard
     16.3.Competition Benchmarking
     16.4.Company Deep Dive
            16.4.1. Teva Pharmaceutical Industries Ltd.
                    16.4.1.1. Overview
                    16.4.1.2. Product and Application Portfolio
                    16.4.1.3. Production Footprint
                    16.4.1.4. Sales Footprint
                    16.4.1.5. Channel Footprint
                    16.4.1.6. Strategy
                                   16.4.1.6.1. Marketing Strategy
                                   16.4.1.6.2. Product Strategy
                                   16.4.1.6.3. Channel Strategy
            16.4.2. Novartis AG
                    16.4.2.1. Overview
                    16.4.2.2. Product and Application Portfolio
                    16.4.2.3. Production Footprint
                    16.4.2.4. Sales Footprint
                    16.4.2.5. Channel Footprint
                    16.4.2.6. Strategy
                                   16.4.2.6.1. Marketing Strategy
                                   16.4.2.6.2. Product Strategy
                                   16.4.2.6.3. Channel Strategy
            16.4.3. Allergan plc
                    16.4.3.1. Overview
                    16.4.3.2. Product and Application Portfolio
                    16.4.3.3. Production Footprint
                    16.4.3.4. Sales Footprint
                    16.4.3.5. Channel Footprint
                    16.4.3.6. Strategy
                                   16.4.3.6.1. Marketing Strategy
                                   16.4.3.6.2. Product Strategy
                                   16.4.3.6.3. Channel Strategy
            16.4.4. Mylan N.V.
                    16.4.4.1. Overview
                    16.4.4.2. Product and Application Portfolio
                    16.4.4.3. Production Footprint
                    16.4.4.4. Sales Footprint
                    16.4.4.5. Channel Footprint
                    16.4.4.6. Strategy
                                   16.4.4.6.1. Marketing Strategy
                                   16.4.4.6.2. Product Strategy
                                   16.4.4.6.3. Channel Strategy
            16.4.5. Pfizer Inc.
                    16.4.5.1. Overview
                    16.4.5.2. Product and Application Portfolio
                    16.4.5.3. Production Footprint
                    16.4.5.4. Sales Footprint
                    16.4.5.5. Channel Footprint
                    16.4.5.6. Strategy
                                   16.4.5.6.1. Marketing Strategy
                                   16.4.5.6.2. Product Strategy
                                   16.4.5.6.3. Channel Strategy
            16.4.6. Purdue Pharma L.P
                    16.4.6.1. Overview
                    16.4.6.2. Product and Application Portfolio
                    16.4.6.3. Production Footprint
                    16.4.6.4. Sales Footprint
                    16.4.6.5. Channel Footprint
                    16.4.6.6. Strategy
                                   16.4.6.6.1. Marketing Strategy
                                   16.4.6.6.2. Product Strategy
                                   16.4.6.6.3. Channel Strategy
            16.4.7. Janssen Pharmaceuticals, Inc.
                    16.4.7.1. Overview
                    16.4.7.2. Product and Application Portfolio
                    16.4.7.3. Production Footprint
                    16.4.7.4. Sales Footprint
                    16.4.7.5. Channel Footprint
                    16.4.7.6. Strategy
                                   16.4.7.6.1. Marketing Strategy
                                   16.4.7.6.2. Product Strategy
                                   16.4.7.6.3. Channel Strategy
            16.4.8. Endo International plc
                    16.4.8.1. Overview
                    16.4.8.2. Product and Application Portfolio
                    16.4.8.3. Production Footprint
                    16.4.8.4. Sales Footprint
                    16.4.8.5. Channel Footprint
                    16.4.8.6. Strategy
                                   16.4.8.6.1. Marketing Strategy
                                   16.4.8.6.2. Product Strategy
                                   16.4.8.6.3. Channel Strategy
            16.4.9. Pacira Pharmaceuticals Inc.
                    16.4.9.1. Overview
                    16.4.9.2. Product and Application Portfolio
                    16.4.9.3. Production Footprint
                    16.4.9.4. Sales Footprint
                    16.4.9.5. Channel Footprint
                    16.4.9.6. Strategy
                                   16.4.9.6.1. Marketing Strategy
                                   16.4.9.6.2. Product Strategy
                                   16.4.9.6.3. Channel Strategy
            16.4.10. Egalet Corporation
                    16.4.10.1. Overview
                    16.4.10.2. Product and Application Portfolio
                    16.4.10.3. Production Footprint
                    16.4.10.4. Sales Footprint
                    16.4.10.5. Channel Footprint
                    16.4.10.6. Strategy
                                   16.4.10.6.1. Marketing Strategy
                                   16.4.10.6.2. Product Strategy
                                   16.4.10.6.3. Channel Strategy
            16.4.11. GlaxoSmithKline Plc.
                    16.4.11.1. Overview
                    16.4.11.2. Product and Application Portfolio
                    16.4.11.3. Production Footprint
                    16.4.11.4. Sales Footprint
                    16.4.11.5. Channel Footprint
                    16.4.11.6. Strategy
                                   16.4.11.6.1. Marketing Strategy
                                   16.4.11.6.2. Product Strategy
                                   16.4.11.6.3. Channel Strategy

17. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     17.1.Introduction/Key Findings
     17.2.Historical Market Size (US$ Mn) Analysis By Region, 2013–2017
     17.3.Market Size (US$ Mn) Forecast By Region, 2018–2026
            17.3.1. North America
            17.3.2. Latin America
            17.3.3. Europe
            17.3.4. Asia Pacific excluding China
            17.3.5. China
            17.3.6. Middle East & Africa
     17.4.Market Attractiveness Analysis By Region

18. Global Postoperative Pain Management Analysis 2013–2017 and Forecast 2018–2026, By Drug Class
     18.1.Introduction/Key Findings
     18.2.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
            18.2.1. NSAIDS
            18.2.2. Opioids
            18.2.3. Local Anaesthetics
            18.2.4. Acetaminophen
     18.3.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
     18.4.Market Attractiveness Analysis By Drug Class

19. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Route of Administration
     19.1.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
            19.1.1. Injectables
            19.1.2. Oral
            19.1.3. Topical
            19.1.4. Transdermal
            19.1.5. Others
     19.2.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
     19.3.Market Attractiveness Analysis By Route of Administration

20. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
     20.1.Introduction/Key Findings
     20.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
            20.2.1. Hospital Pharmacies
            20.2.2. Retail Pharmacies
            20.2.3. Drug Store
            20.2.4. Clinics
            20.2.5. Others
     20.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
     21.1.Market Value Projections
     21.2.Y-o-Y Growth Analysis
     21.3.Absolute $ Opportunity

22. Research Methodology


List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Country
Table 04 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Drug Class
Table 05 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Route of Administration
Table 06 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Distribution Channel
Table 07 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 09 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 10 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 11 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 12 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 13 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 14 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 15 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 16 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 17 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 18 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 19 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 20 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 21 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 22 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 24 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 25 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 26 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Region
Table 27 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Drug Class
Table 28 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Route of Administration
Table 29 : Global Prescription  Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Distribution Channel


List of Figures

Figure 01 : Global Postoperative Pain Management Market value (US$ Mn) Forecast, 2018 – 2026
Figure 02 : Global Postoperative Pain Management Market Share, By Drug Class (2018)
Figure 03 : Global Postoperative Pain Management Market Share, By Region (2018)
Figure 04: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 05 : North America Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 06 : North America Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 07 : North America Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 08 : North America Postoperative Pain Management Market Share, By Country (2018 E)
Figure 09 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 10 : North America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 11 : U.S. Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 12 : U.S. Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 13 : Canada Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 14 : Canada Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 15 : North America Postoperative Pain Management Market Attractiveness Analysis, By Country
Figure 16 : North America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 17: North America Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration
Figure 18 : North America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 19 : Latin America Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 20 : Latin America Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 21 : Latin America Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 22 : Latin America Postoperative Pain Management Market Share, By Country (2018 E)
Figure 23 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 24 : Latin America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 25 : Brazil Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 26 : Brazil Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 27 : Mexico Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 28 : Mexico Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 29 : Rest of Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 30 : Rest of Latin America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 31 : Latin America Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 32 : Latin America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 33 : Latin America Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 34 : Latin America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 35 : Europe Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 36 : Europe Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 37 : Europe Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 38 : Europe Postoperative Pain Management Market Share, By Country (2018 E)
Figure 39 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 40 : Europe Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 41 : U.K. Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 42 : U.K. Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 43 : Germany Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 44 : Germany Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 45: France Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 46 :France Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 47 : Italy Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 48 :Italy Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 49 : Spain Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 50 : Spain Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 51 : Russia Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 52 : Russia Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 53 : Rest of Europe Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 54 : Rest of Europe Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 55 : Europe Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 56 : Europe Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 57 : Europe Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 58 : Europe Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 59 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 60 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 61 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 62 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Country (2018 E)
Figure 63 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 64 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 65 : Japan Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 66 : Japan Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 67 : India Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 68 : India Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 69 : Australia and New Zealand Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 70 : Australia and New Zealand Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 71 : ASEAN Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 72 : ASEAN Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 73 : Rest of Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 74 : Rest of Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 75 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 76 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 77 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 78 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 79 : China Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 80 : China Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 81 : China Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 82 : China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 83 : China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 84 : China Postoperative Pain Management Market Attractiveness Analysis, , By Drug Class
Figure 85 : China Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration
Figure 86 : China Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 87 : Middle East & Africa Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 88 : Middle East & Africa Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 89 : Middle East & Africa Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 90 : Middle East & Africa Postoperative Pain Management Market Share, By Country (2018 E)
Figure 91 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 92 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 93 : South Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 94 : South Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 95 : GCC Countries Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 96 : GCC Countries Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 97 : Rest of Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 98 : Rest of Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 99 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 100 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
 Figure 101 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 102 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 103 : Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2026
Figure 104 : Global Postoperative Pain Management Market Attractiveness Analysis, By Region (2018 - 2026)
Figure 105 : Global Postoperative Pain Management Market Value (US$ Mn), By Drug Class, 2018 & 2026
Figure 106 : Global Postoperative Pain Management Market Attractiveness Analysis, By Drug Class (2018 - 2026)
Figure 107 :Global Prescription Analgesics Market Value (US$ Mn), By Route of Administration, 2018 & 2026
Figure 108 : Global Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration (2018 - 2026)
Figure 109 : Global Postoperative Pain Management Market Value (US$ Mn), By Distribution Channel, 2018 & 2026
Figure 110 : Global Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel (2018 - 2026)
Figure 111 : Global Postoperative Pain Management Historical Market Size and Y-o-Y, 2013- 2017.
Figure 112 : Global Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2026.
Figure 113 : Global Postoperative Pain Management Market Absolute $ Opportunity, 2017–2026,